Mucosal haemangioma in the setting of treatment with trastuzumab emtansine (T-DM1). Belzer A, Silber A, Mehra S, Gilani S, et al. Br J Dermatol 2022;187:e168.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Belzer A, Silber A, Mehra S, Gilani S, et al. Mucosal haemangioma in the setting of treatment with trastuzumab emtansine (T-DM1). Br J Dermatol 2022;187:e168.
PMID: 35633104